CLINICAL_TRIALS
trial_result
· 2011-05-30
Clinical Trial Update: A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis [Phase 3]
Summary
A Phase 3 clinical trial evaluating Botulinum toxin Type A for axillary hyperhidrosis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Hyperhidrosis | Phase 3 | Status: COMPLETED